BMJ 1997;315:510-514 (30 August)
Papers
Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study
Oliver Blatchford,
audit research
fellow,a
Lindsay A Davidson,
director of
audit,a
William R Murray,
consultant
surgeon,b
Mary Blatchford,
general
practitioner,c
Jill Pell,
senior registrar in public
health medicine da Royal College of Physicians and Surgeons of Glasgow, Glasgow G2 5RJ,
b Glasgow Royal Infirmary NHS Trust, Glasgow G31 2ER,
c Easterhouse Health Centre, Glasgow G34 9HQ,
d Department of Public Health, Greater Glasgow Health Board, Glasgow G1 1ET
Correspondence to: Dr O Blatchford Department of Public Health, University of Glasgow, Glasgow G12 8RZ o.blatchford@udcf.gla.uk
Objectives: To determine the incidence and case
fatality of acute upper gastrointestinal haemorrhage in the west of Scotland and to identify
associated factors.
Design: Case ascertainment study.
Setting: All hospitals treating adults with acute
upper
gastrointestinal haemorrhage in the west of Scotland.
Subjects: 1882 patients aged 15 years and over
treated
in hospitals for acute upper gastrointestinal haemorrhage during a six month period.
Main outcome measures: Incidence of acute upper
gastrointestinal haemorrhage per 100 000 population per year, and case fatality.
Results: The annual incidence was 172 per 100 000
people aged 15 and over. The annual population mortality was 14.0 per 100 000. Both were
higher
among elderly people, men, and patients resident in areas of greater social deprivation. Overall
case
fatality was 8.2%. This was higher among those who bled as inpatients after admission
for
other reasons (42%) and those admitted as tertiary referrals (16%). Factors
associated
with increased case fatality were age, uraemia, pre-existing malignancy, hepatic failure,
hypotension, cardiac failure, and frank haematemesis or a history of syncope at presentation.
Social
deprivation, sex, and anaemia were not associated with increased case fatality after adjustment
for
other factors.
Conclusions: The incidence of acute upper
gastrointestinal haemorrhage was 67% greater than the highest previously reported
incidence
in the United Kingdom, which may be partially attributable to the greater social deprivation in
the
west of Scotland and may be related to the increased prevalence of Helicobacter pylori. Fatality after acute upper gastrointestinal
haemorrhage was associated with age, comorbidity, hypotension, and raised blood urea
concentrations on admission. Although deprivation was associated with increased incidence, it
was
not related to the risk of fatality.
|
Key messages
- The incidence of upper gastrointestinal haemorrhage in the west of Scotland was
67%
higher than the highest incidence previously reported in the United Kingdom
- A substantial part of this excess incidence may be attributable to socioeconomic
deprivation
- The overall population mortality from upper gastrointestinal haemorrhage may increase
as
the elderly population increases because both incidence and case fatality rise steeply with
age
- A reduction in the overall case fatality from acute upper gastrointestinal haemorrhage will
be best achieved by reducing case fatality among elderly patients
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
- Julia Hippisley-Cox, Carol Coupland, and Richard Logan
BMJ 2005 331: 1310-1316.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Robins, G G, Sarwar, M S, Armstrong, M, Denyer, M E, Bush, S, Hassan, T, Everett, S M
(2007). Evaluation of the need for endoscopy to identify low-risk patients presenting with an acute upper gastrointestinal bleed suitable for early discharge. Postgrad. Med. J.
83: 768-772
[Abstract]
[Full text]
-
Sung, J. J Y, Tsoi, K. K F, Lai, L. H, Wu, J. C Y, Lau, J. Y W
(2007). Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut
56: 1364-1373
[Abstract]
[Full text]
-
Williams, J G, Roberts, S E, Ali, M F, Cheung, W Y, Cohen, D R, Demery, G, Edwards, A, Greer, M, Hellier, M D, Hutchings, H A, Ip, B, Longo, M F, Russell, I T, Snooks, H A, Williams, J C
(2007). Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut
56: 1-113
[Full text]
-
Hippisley-Cox, J., Coupland, C., Logan, R.
(2005). Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ
331: 1310-1316
[Abstract]
[Full text]
-
(2004). Proton pump inhibitors for acute upper GI bleeding. DTB
42: 41-43
[Abstract]
[Full text]
-
Courtney, A E, Mitchell, R M S, Rocke, L, Johnston, B T
(2004). Proposed risk stratification in upper gastrointestinal haemorrhage: Is hospitalisation essential?. Emerg. Med. J.
21: 39-40
[Abstract]
[Full text]
-
Barkun, A., Bardou, M., Marshall, J. K., for the Nonvariceal Upper GI Bleeding Consensus Co,
(2003). Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. ANN INTERN MED
139: 843-857
[Abstract]
[Full text]
-
van Walraven, C, Mamdani, M M, Wells, P S, Williams, J I
(2001). Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ
323: 655-655
[Abstract]
[Full text]